Bwdelccg GB Mic 131119 Papers
Total Page:16
File Type:pdf, Size:1020Kb
BLACKBURN WITH DARWEN CLINICAL COMMISSIONING GROUP EAST LANCASHIRE CLINICAL COMMISSIONING GROUP Blackburn with Darwen Clinical Commissioning Group Governing Body and East Lancashire Clinical Commissioning Group Governing Body Meeting in Common The meeting will Wednesday, 13 November 2019, 13:00-15:00 be digitally The ACE Centre, Cross Street, Nelson BB9 7NN recorded AGENDA PART 1 Item Lead Strategic Report/ Time Objective Category 1 Welcome, Introductions and Chair’s Update Dr R Robinson Verbal 13:00 Chair 2 Patient and Public Involvement 2.1 Patient Story (Prostate Cancer) Mr D Rogers Video 13:05 Presentation 2.2 Public Questions Dr R Robinson Verbal 13:25 3 Governance Arrangements 3.1 Apologies for Absence and Confirmation of Dr R Robinson Verbal Quoracy 3.2 Declarations of Interest Dr R Robinson Verbal Members and Attendees are requested to identify any interests relating specifically to the agenda items (see guide below) and inform the Chair and Governing Body Secretary in advance of the meeting. 3.3 Declarations of Other Business Dr R Robinson Verbal 3.4 Minutes of the previous Governing Body 13:30 Meetings and Matters Arising: a. Blackburn with Darwen Clinical Mr G Burgess Attached Commissioning Group held on 11th September 2019 b. Blackburn with Darwen Clinical Mr G Burgess Attached Commissioning Group Extract from Part 2 held on 11th September 2019 c. Blackburn with Darwen Clinical Mr G Burgess Attached Commissioning Group Annual General Meeting held on 11th September 2019 d. East Lancashire Clinical Commissioning Dr R Robinson Attached Group held on 4th September 2019 e. East Lancashire Clinical Commissioning Dr R Robinson Attached Group Annual General Meeting held on 4th September 2019 3.5 Action Matrix 13:35 a. Blackburn with Darwen Clinical Mr G Burgess Attached Commissioning Group b. East Lancashire Clinical Commissioning Dr R Robinson Attached Group 4 Business 4.1 Integrated Care System Update 13:40 Integrated Care System Strategic Plan Mrs C Richardson Presentation Development 4.2 Integrated Care Partnership Update Mr A Walker To Follow 13:50 Accelerator Report Dr M Dziobon CCG Business 4.3 Joint Chief Officer Report Dr J Higgins Attached 14:00 4.4 Corporate Business Plan Dr J Higgins Attached 14:05 4.5 Performance Report Mr R Parr Attached 14:15 4.6 Finance Report 14:25 a. Blackburn with Darwen Clinical Mr R Parr Attached Commissioning Group b. East Lancashire Clinical Commissioning Mrs K Hollis Attached Group 4.7 Quality Assurance Report Mrs K Hollis To Follow 14:35 Blackburn with Darwen Clinical Commissioning Group Specific Business No specific items East Lancashire Clinical Commissioning Group Specific Business No specific items 5 Reports Presented for Information 5.1 Safeguarding Annual Update Mrs D Ross Presentation 14:40 Mrs S Clarke 5.2 Sub Committee Summary and Stakeholder 14:55 Minutes a. Blackburn with Darwen Clinical Attached Commissioning Group Mrs D Atkinson b. East Lancashire Clinical Commissioning Attached Group 5.3 Accident and Emergency Delivery Board Mr A Walker Attached Chair’s Report 5.4 Pennine Lancashire Emergency Preparedness Mrs K Hollis Attached Submission Blackburn with Darwen Clinical Commissioning Group Specific Item 5.5 Blackburn with Darwen Health and Well-Being Prof D Harrison Attached Annual Report 2018/19 6 Any Other Business 6.1 Items for inclusion on the Corporate Risk Register 7 Date and Time of Next Meeting Wednesday, 15 January 2020, 13:00 hrs Meeting Rooms 1 and 2 at Blackburn Central Library, Town Hall Street, Blackburn BB2 1AG RESOLUTION “That representatives of the press and other members of the public be excluded from the remainder of the meeting having regard to the confidential nature of the business to be transacted, publicity on which would be prejudicial to the public interest.” (Section 1[2] Public Bodies (Admission to Meetings) Act 1960. Types of Interest Type of Description Interest Financial This is where an individual may get direct financial benefits from the consequences of a Interests commissioning decision. This could, for example, include being: A director, including a non-executive director, or senior employee in a private company or public limited company or other organisation which is doing, or which is likely, or possibly seeking to do, business with health or social care organisations; A shareholder (or similar owner interests), a partner or owner of a private or not-for- profit company, business, partnership or consultancy which is doing, or which is likely, or possibly seeking to do, business with health or social care organisations. A management consultant for a provider; In secondary employment (see paragraph 56 to 57); In receipt of secondary income from a provider; In receipt of a grant from a provider; In receipt of any payments (for example honoraria, one off payments, day allowances or travel or subsistence) from a provider In receipt of research funding, including grants that may be received by the individual or any organisation in which they have an interest or role; and Having a pension that is funded by a provider (where the value of this might be affected by the success or failure of the provider). Non- This is where an individual may obtain a non-financial professional benefit from the Financial consequences of a commissioning decision, such as increasing their professional Professional reputation or status or promoting their professional career. This may, for example, include Interests situations where the individual is: An advocate for a particular group of patients; A GP with special interests e.g., in dermatology, acupuncture etc. A member of a particular specialist professional body (although routine GP membership of the RCGP, BMA or a medical defence organisation would not usually by itself amount to an interest which needed to be declared); An advisor for Care Quality Commission (CQC) or National Institute for Health and Care Excellence (NICE); A medical researcher. Non- This is where an individual may benefit personally in ways which are not directly linked to Financial their professional career and do not give rise to a direct financial benefit. This could Personal include, for example, where the individual is: Interests A voluntary sector champion for a provider; A volunteer for a provider; A member of a voluntary sector board or has any other position of authority in or connection with a voluntary sector organisation; Suffering from a particular condition requiring individually funded treatment; A member of a lobby or pressure groups with an interest in health. Indirect This is where an individual has a close association with an individual who has a financial Interests interest, a non-financial professional interest or a non-financial personal interest in a commissioning decision (as those categories are described above). For example, this should include: Spouse / partner; Close relative e.g., parent, grandparent, child, grandchild or sibling; Close friend; Business partner. NHS Blackburn with Darwen Clinical Commissioning Group NHS East Lancashire Clinical Commissioning Group Item 2.1 Patient Story: Lloyd Pinder: Prostate Cancer Briefing Notes for Governing Body Members In the UK, prostate cancer is the most common cancer in men. Across the country, there are more than 333,500 men living with and beyond the disease. Many are dealing with serious side effects from treatment. Movember is an annual event involving the growing of moustaches during the month of November to raise awareness of men's health issues, such as prostate cancer, testicular cancer, and men's suicide. The Movember Foundation runs the Movember charity event, housed at Movember.com. The CCG actively promotes Movember throughout November! For prostate cancer this means Movember is about helping men, and their families and friends to know the signs, symptoms and risk factors to ensure early diagnosis, treatment and better outcomes, as well as prevention. In this video, having been diagnosed with advanced prostate cancer, Lloyd Pinder records his determination to outlive his prognosis for the sake of his young daughters and to help other men avoid his fate. Key statistics Around 363,000 new cancer cases in the UK every year, that's more than 990 every day (2014-2016). Every two minutes someone in the UK is diagnosed with cancer. Breast, prostate, lung and bowel cancers together accounted for over half (53%) of all new cancer cases in the UK in 2016. In males in the UK, prostate cancer is the 2nd most common cause of cancer death. Incidence rates for all cancers combined in the UK are highest in people aged 85 to 89 (2014-2016). Over the last decade, prostate cancer incidence rates have increased by around a twentieth (4%) in males in the UK Around 4 in 10 prostate cancer cases are diagnosed at a late stage in England (2014) Prostate cancer in England is less common in males living in the most deprived areas Prostate cancer is most common in Black males, then White males and least common in Asian males An estimated 280,500 men who had previously been diagnosed with prostate cancer were alive in the UK at the end of 2010 Diagnosis and Treatment 'Two-week wait' is the most common route to diagnosing prostate cancer GP referral is the route with the highest proportion of cases diagnosed at an early stage, for prostate cancer Prostate cancer: diagnosis and management: NICE guideline [NG131]: May 2019 Rapid diagnostic and assessment pathways – Implementing a timed prostate cancer diagnostic pathway (A handbook for local